skinny.

Latest / Parkinson's Disease Education Podcast

From Lab Bench to Brain: The Truth About Ivermectin and Parkinson's

In this episode (watch on YouTube) we examine recent lab and animal research suggesting ivermectin — a widely used antiparasitic — can alter striatal circuits and enhance L-DOPA responses in preclinical Parkinson's models.

We'll explain the likely mechanisms (ion-channel modulation at P2X4 and nicotinic receptors), review safety concerns (blood-brain-barrier and neurotoxicity risks), and explain why there are no human trials yet proving efficacy in Parkinson's.

Sources and further reading are here:

1. Ivermectin increases striatal cholinergic activity to facilitate dopamine terminal function…

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.